Clinical Trial Update: Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1-2 clinical trials evaluated OT-730 Eye Drops for reducing intraocular pressure in adults with ocular hypertension or open-angle glaucoma; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• OT-730 Eye Drops (OT-730)

Snippet

Sponsor: Othera Pharmaceuticals | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED